| Product Type | Impurity Standards |
| CAT. No. | MRL-D28008 |
| CAS. No. | 1412898-66-8 |
| Mol. Formula | C41H55NO14 |
| Mol. Weight | 785.88 |
| Synonyms | 2-Debenzoyl-2-pentenoyldocetaxel |
| Chemical Name | (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-9-(((2R,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2 |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | Custom Synthesis |
Docetaxel Impurity 19 with CAS No:1412898-66-8 is an impurity standard of Docetaxel. Docetaxel is a chemotherapy medication belonging to the taxane class and is commonly used in the treatment of various cancers, including breast cancer, lung cancer, and prostate cancer. Its mechanism of action involves disrupting the microtubule structures in cancer cells, preventing their normal function and inhibiting cell division. By interfering with the cancer cell cycle, docetaxel helps to slow down or stop the growth and spread of cancer cells. This chemotherapy agent is typically administered intravenously and may be part of combination therapies for different types of cancer. While effective, docetaxel is associated with potential side effects, and its use is carefully managed by healthcare professionals based on the specific cancer type and the patients overall health condition. Buy high quality Docetaxel Impurity 19 from from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Docetaxel Impurity 19